Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Dana-Farber Cancer Institute
The objective of this study is to implement an intervention in a pragmatic randomized controlled trial that uses cancer treatment pathways data to identify patients appropriate for serious illness conversations (SICs) and applies "nudges" to patients and their oncology clinicians to increase SICs and improve end of life (EOL) outcomes.
Identified participants and clinicians will be randomized into 1 or 4 groups.
* Nudge to patient and clinician
* Nudge to patient only
* Nudge to clinician only
* No nudge.
The expected enrollment is approximately 800 participants.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who are aged 18 years or older, reach one of the poor prognosis nodes identified and have an upcoming appointment at one of the following Dana Farber Cancer Institute oncology clinics (including Longwood and Chestnut Hill locations)
Breast Oncology Clinic
Gastrointestinal Oncology Clinic
Genitourinary Oncology Clinic
Gynecologic Oncology Clinic
Thoracic Oncology Clinic
You may not be if
Patients with an SIC documented in the Advance Care Planning module of the electronic health record in the 6 months prior to reaching a poor prognosis node
Patients who have previously been randomized in this trial (e.g., the patient is encountering a poor-prognosis node for the second time during the trial period)
Clareo Health | Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)
